Professor, Doctor of Medical Sciences
Head of the Department of Radiation Therapy and Radiation Oncology
Recognized as one of Germany’s Best Doctors in “Radiation Therapy” by Focus magazine (2025)

Professional Memberships

• Chair of the German Society for Radiation Oncology

• Active member of the European Society for Therapeutic Radiology and Oncology (ESTRO)

• Member of the American Society for Therapeutic Radiology and Oncology (ASTRO)

• Member of the German Society for Radio-Oncology

• Member of the Professional Association of German Radiation Therapy Specialists

• Member of the German Cancer Society

• Head of the Radiation Safety Compliance Department at the North Rhine Medical Chamber

Scientific Awards and Key Research Projects

• AGA HBO Award (1999)

• Hans Langendorff Award (2001) for the study “Gene therapy using a dominant-negative mutant of EGFR increases radiosensitivity in glioblastoma and breast cancer”
  (Co-authors: G. Lammering, T. Hewit, W. Hawkins, K. Valerie, P.S. Lin, G. Schmitt, R. Schmidt-Ullrich)

• Theragnostic MedTech Poster Award (2001) for the research “Remission rates and outcomes of breast-conserving treatment: preoperative chemotherapy versus combined chemoradiotherapy”
  (Co-authors: B. Gerlach, R. Rohn, G. Schmitt, P. Dimmerling, W. Audretsch, F. Gogolin, T. Königshausen, R. Willers)

• Dr. Mildred Scheel Foundation Grants for Oncology Research:

  1996–1998, Amsterdam: “Studies on tumor oxygenation in R1H rat rhabdomyosarcoma”
  2000–2001, Amsterdam: “Studies on human glioma cell lines: genetic alterations and sensitivity to chemo-/radiotherapy”

• 2001 Funding of a research assistant at the Hyperbaric Oxygenation Center, University of Düsseldorf (initiated by the Parents’ Association of the Pediatric Oncology Clinic)

• Joint Research Funding with the Interdisciplinary Mammology Center, Düsseldorf Hospital (Gerresheim) for the study:
  “Prospective randomized multifactorial trial on optimizing therapy with Paclitaxel and Epirubicin in patients with primarily anatomically and/or oncologically partially or completely inoperable breast cancer.”

Participation in Congresses and Conferences

• 7th German Congress for Radio-Oncology, Radiobiology, and Medical Physics, Hamburg

• 23rd International Congress of the International Association for Breast Cancer Research, Düsseldorf

• 5th German Congress for Radio-Oncology, Radiobiology, and Medical Physics, Karlsruhe

• “Hyperbaric Oxygenation in Radiation Therapy: The Role of Respiratory Hyperoxia”, Düsseldorf